首页> 外文期刊>Environmental Science and Pollution Research >Acute oral toxicity study on Wistar rats fed microalgal protein hydrolysates from Bellerochea malleus
【24h】

Acute oral toxicity study on Wistar rats fed microalgal protein hydrolysates from Bellerochea malleus

机译:急性口腔毒性研究Wistar大鼠来自贝勒科氏症的微藻蛋白水解液

获取原文
获取原文并翻译 | 示例
           

摘要

Protein hydrolysates and bioactive peptides from various protein sources have demonstrated their effectiveness for the prevention of illness and the improvement of symptoms from several diseases. In particular, the use of microalgae to generate bioactive peptides has received a growing interest because of their potential to be cultivated on non-arable land and high nutritional value. However, scant research is available on the toxicity of peptide-based preparations. The present study aims to evaluate the toxicity of microalgal protein hydrolysates (MPH) from one marine species of microalgae (Bellerochea malleus) to determine the feasibility of their use for functional food applications. Results showed that the oral administration of MPH at three doses (D1, 100 mg kg~(-1) BW; D2, 400 mg kg~(-1) BW; and D3, 2000 mg kg~(-1) BW) to male Wistar rats did not induce any adverse effects or mortality up to13 days of treatment. Data analysis of relative organ weights and biochemical and hematological parameters did not show any significant differences between control and treated groups at the three doses investigated. Data from histopathological observations did not reveal any signs of major toxicity at the doses D1 and D2. However, mild signs of inflammation and necrosis were observed in the kidney of rats fed MPH at D3. All together, these results reveal the overall safety of MPH and provide new evidence for advocating their use for functional food or nutraceutical applications.
机译:来自各种蛋白质来源的蛋白质水解酸盐和生物活性肽已经证明了它们对预防疾病的有效性以及来自几种疾病的症状的改善。特别地,由于它们在非耕地和高营养价值上培养,因此使用微藻生成生物活性肽的使用已经产生了生物活性肽。然而,味道研究可用于肽基制剂的毒性。本研究旨在评估微藻蛋白水解酸盐(MPH)的微藻(Bellerochea Malleus)的毒性,以确定其用于功能性食品应用的可行性。结果表明,三剂量(D1,100mg kg〜(-1)BW; D2,400mg kg〜(-1)BW; D3,2000mg kg〜(-1)bw)口服施用Mph;雄性Wistar大鼠没有诱导任何不良反应或死亡率最高到13天的治疗。相对器官重量和生物化学和血液学参数的数据分析并未显示在研究中的三种剂量下对照和治疗组之间的任何显着差异。来自组织病理学观察的数据并未揭示剂量D1和D2的主要毒性迹象。然而,在D3喂养MPH的大鼠肾脏中观察到温和炎症和坏死的迹象。所有这些结果都揭示了MPH的整体安全,并为倡导其使用功能食品或营养保健应用提供了新的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号